A Multicenter Randomized Study to Compare the Safety and Efficacy of Low-dose Versus Standard Dose Lopinavir/Ritonavir Containing HAART Regimen in Virological Suppressed HIV-infected Thai Children.

Trial Profile

A Multicenter Randomized Study to Compare the Safety and Efficacy of Low-dose Versus Standard Dose Lopinavir/Ritonavir Containing HAART Regimen in Virological Suppressed HIV-infected Thai Children.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Oct 2015

At a glance

  • Drugs Lopinavir/ritonavir (Primary) ; Nucleoside reverse transcriptase inhibitors
  • Indications HIV infections
  • Focus Therapeutic Use
  • Acronyms PEARL
  • Most Recent Events

    • 03 Jul 2013 Substudy results presented at the 7th International AIDS Society Conference on HIV Pathogenesis and Treatment.
    • 03 Jul 2013 Status changed from active, no longer recruiting to completed, based on resuts presented at the 7th International AIDS Society Conference on HIV Pathogenesis and Treatment.
    • 03 Jul 2013 Results presented at the 7th International AIDS Society Conference on HIV Pathogenesis and Treatment.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top